Clinical Trial: USOR 21400

Trial Status: Closed
Disease Types: Solid Tumors All, Gynecologic
Trial ID USOR 21400
Sponsor ID TJ004309STM103

A Phase 2 Clinical Study of TJ004309 in Combination with Atezolizumab in Patients with Advanced or Mets Ovarian Cancer and Selected Advanced Solid Tumors.


Fairfax Office

Gainesville Office

Loudoun Office

Alexandria Office

Learn More About This Trial

Other Relevant Trials
Trial ID TSC-007

A Phase 2 multi-center open-label basket trial of ABI-009 (nab-sirolimus) for adult and adolescent patients with solid tumors harboring pathogenic inactivating alterations in TSC1 or TSC2 genes

Trial ID 21457
Sponsor ID Artistry-7

(ALKS 4230-007/GOG-3063) A Phase 3, Multicenter, Open-Label, Randomized Study of Nemvaleukin Alfa in Combination With Pembrolizumab Versus Investigator’s Choice Chemotherapy in Patients With Platinum-Resistant Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ARTISTRY-7)

Principal Investigator
Robert L. Marsh, MD
5 Locations